Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.340
+0.170 (7.83%)
Nov 20, 2025, 4:00 PM EST - Market closed
Palisade Bio Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Palisade Bio stock has a target of 16, which predicts a 583.76% increase from the current stock price of 2.34.
Price Target: $16 (+583.76%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Palisade Bio is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Strong Buy Maintains $16 | Strong Buy | Maintains | $16 | +583.76% | May 13, 2025 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +1,523.93% | Nov 20, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 → $8 | Strong Buy | Maintains | $23 → $8 | +241.88% | Nov 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +861.54% | May 1, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +861.54% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.53
from -10.19
EPS Next Year
-0.78
from -1.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.17 | -0.37 | |||
| Avg | -1.53 | -0.78 | |||
| Low | -1.80 | -1.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.